D-1359-2015 Class II Terminated
FDA drug recall D-1359-2015 was initiated by GlaxoSmithKline, LLC. on Aug 13, 2015 and is designated Class II. Reason for recall: Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process. The recall status is terminated (terminated Mar 21, 2017). Affected quantity: 88,489 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 2, 2015
- Initiation Date
- Aug 13, 2015
- Termination Date
- Mar 21, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 88,489 tubes
Product description
Bactroban (mupirocin calcium) Nasal Ointment, 2% 1g tube, Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217. NDC 0029-1526-11
Reason for recall
Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: C704202, Exp 11/2016; Lot #: C706532, Exp 12/2016; Lot #: C713177, Exp 1/2017; Lot #: C716567, Exp 2/2017, Lot #: C720097, C720098, Exp 3/2017, Expanded to include: C720096, Exp. 2/2017.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1359-2015
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026